Li Zhang

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0001-5533-8568

发表论文 30 篇 · 总被引 757 次 · h-index 12

代表论文

• Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy (2020 · Science Advances · 被引 126)
• Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer (2024 · JAMA Surgery · 被引 50)
• Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer (2025 · Nature Communications · 被引 44)
• Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer (2022 · OncoImmunology · 被引 41)
• China Protocol for early screening, precise diagnosis, and individualized treatment of lung cancer (2025 · Signal Transduction and Targeted Therapy · 被引 23)
• Comparison of Short-term and Three-year Oncological Outcomes Between Robotic and Laparoscopic Gastrectomy for Gastric Cancer (2024 · Annals of Surgery · 被引 23)